Related Experiment Video

Updated: Sep 13, 2026

Rapid Molecular Detection and Differentiation of Influenza Viruses A and B
05:38

Rapid Molecular Detection and Differentiation of Influenza Viruses A and B

Published on: January 30, 2017

[Effectiveness of oseltamivir treatment against influenza type A and type B infection in children]

Keiko Mitamura1, Norio Sugaya, Mari Nirasawa

  • 1Department of Pediatrics, Nippon Kokan Hospital.

Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases
|January 2, 2003
PubMed

Insights

Oseltamivir effectively treats influenza in children, with most recovering within two days when treatment begins early. This antiviral medication showed consistent results across different age groups and influenza types, with no observed side effects.

Area of Science:

  • Pediatric infectious diseases
  • Virology
  • Pharmacology

Context:

  • Influenza virus infections pose a significant health burden in pediatric populations.
  • Antiviral medications are crucial for managing influenza symptoms and reducing transmission.
  • The 2001-2002 influenza epidemic necessitated evaluating treatment efficacies.

Purpose:

  • To assess the clinical effectiveness of oseltamivir in treating influenza virus infection in children.
  • To determine the impact of early oseltamivir initiation on fever duration and recovery time.
  • To evaluate oseltamivir's efficacy across different age groups and influenza strains in pediatric patients.

Summary:

  • A study involving 131 children diagnosed with influenza evaluated oseltamivir treatment (4 mg/kg/day for 5 days).
  • Early initiation of oseltamivir (within 48 hours of fever onset) resulted in 44% of patients becoming afebrile within one day and 86% recovering within two days.
  • The average fever duration was 1.7 days, with oseltamivir demonstrating equal effectiveness against influenza A and B, and across different pediatric age groups without significant side effects.

Impact:

  • Oseltamivir provides a safe and effective treatment option for pediatric influenza, shortening illness duration.
  • Early intervention with oseltamivir can significantly reduce morbidity associated with influenza in children.
  • Findings support the use of oseltamivir as a first-line antiviral therapy for pediatric influenza cases.

More Related Videos

Optimization of a Quantitative Micro-neutralization Assay10:09

Optimization of a Quantitative Micro-neutralization Assay

Published on: December 14, 2016

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals09:31

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Published on: April 15, 2017

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...